These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8624778)

  • 21. An experimental model of chronic renal allograft rejection in the rat using triple drug immunosuppression.
    Soots A; Lautenschlager I; Krogerus L; Saarinen O; Ahonen J
    Transplantation; 1998 Jan; 65(1):42-6. PubMed ID: 9448142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance of rat liver allografts induced by short-term selective immunosuppression combining monoclonal antibodies directed against CD25 and CD54 with subtherapeutic cyclosporine.
    Gassel HJ; Otto C; Gassel AM; Meyer D; Steger U; Timmermann W; Ulrichs K; Thiede A
    Transplantation; 2000 Mar; 69(6):1058-67. PubMed ID: 10762208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of adhesion molecules on the endothelia of rejecting cardiac allografts.
    Lemström K; Koskinen P; Häyry P
    J Heart Lung Transplant; 1995; 14(2):205-13. PubMed ID: 7779837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversibility of allograft arteriosclerosis after retransplantation to donor strain.
    Mennander A; Häyry P
    Transplantation; 1996 Aug; 62(4):526-9. PubMed ID: 8781620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants.
    Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124
    [No Abstract]   [Full Text] [Related]  

  • 26. Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts.
    Räisänen-Sokolowski A; Vuoristo P; Myllärniemi M; Yilmaz S; Kallio E; Häyry P
    Transpl Immunol; 1995 Dec; 3(4):342-51. PubMed ID: 8665154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
    Räisänen-Sokolowski A; Myllärniemi M; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic rejection of rat aortic allografts. III. Synthesis of major eicosanoids by vascular wall components and effect of inhibition of the thromboxane cascade.
    Mennander A; Tiisala S; Ustinov J; Räisänen A; Paavonen T; Häyry P
    Arterioscler Thromb; 1992 Dec; 12(12):1380-6. PubMed ID: 1450170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor.
    Sihvola R; Koskinen P; Myllärniemi M; Loubtchenkov M; Häyry P; Buchdunger E; Lemström K
    Circulation; 1999 May; 99(17):2295-301. PubMed ID: 10226096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
    Shears LL; Kawaharada N; Tzeng E; Billiar TR; Watkins SC; Kovesdi I; Lizonova A; Pham SM
    J Clin Invest; 1997 Oct; 100(8):2035-42. PubMed ID: 9329968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine-induced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection.
    Mennander A; Paavonen T; Häyry P
    Transplant Proc; 1992 Feb; 24(1):341. PubMed ID: 1539306
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a novel inducible nitric oxide synthase inhibitor in prevention of rat chronic aortic rejections.
    Ouyang J; Xu D; Zhang X; Qi S; Ma A; Jiang W; Chida N; Sudo Y; Tamura K; Daloze P; Chen H
    Transplantation; 2005 May; 79(10):1386-92. PubMed ID: 15912108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation.
    Shen J; Chong AS; Xiao F; Liu W; Huang W; Blinder L; Foster P; Sankary H; Jensik S; McChesney L; Mital D; Williams JW
    Transplantation; 1998 Sep; 66(6):692-8. PubMed ID: 9771831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
    Shimizu H; Takahashi M; Takeda S; Inoue S; Fujishiro J; Hakamata Y; Kaneko T; Murakami T; Takeyoshi I; Morishita Y; Kobayashi E
    Transpl Immunol; 2004 Nov; 13(3):219-27. PubMed ID: 15381205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplant arteriosclerosis in a rat aortic model.
    Isik FF; McDonald TO; Ferguson M; Yamanaka E; Gordon D
    Am J Pathol; 1992 Nov; 141(5):1139-49. PubMed ID: 1443048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term consequences of different immunosuppressive regimens for renal allografts.
    Isoniemi HM; Ahonen J; Tikkanen MJ; von Willebrand EO; Krogerus L; Eklund BH; Höckerstedt KV; Salmela KE; Häyry PJ
    Transplantation; 1993 Mar; 55(3):494-9. PubMed ID: 8456467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis.
    Hillebrands JL; Klatter FA; van den Hurk BM; Popa ER; Nieuwenhuis P; Rozing J
    J Clin Invest; 2001 Jun; 107(11):1411-22. PubMed ID: 11390423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.